Hughes-Wilson Alexandra bought MREO
February 1, 2026 · Form 4 insider transaction
Hughes-Wilson Alexandra bought 61,250 shares of Mereo BioPharma Group plc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
61,250
Price
$0.00
Total value
N/A
InsiderHughes-Wilson Alexandra
RoleOfficer
SecurityShare Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2026
Filing dateFebruary 2, 2026
Shares owned after61,250
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares underlying this share option will vest and become exercisable on February 1, 2027, with the remainder vesting in equal monthly installments for the three years thereafter.; Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.